仙琚制药(002332) - 2020 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2020 was ¥744,695,096.98, a decrease of 10.89% compared to ¥835,738,416.97 in the same period last year[10] - Net profit attributable to shareholders was ¥67,354,593.92, representing an increase of 16.11% from ¥58,010,342.60 year-on-year[10] - The net profit after deducting non-recurring gains and losses was ¥63,293,446.50, up 12.50% from ¥56,262,217.21 in the previous year[10] - The basic earnings per share increased to ¥0.07, a rise of 16.67% compared to ¥0.06 in the same period last year[10] - The company's total operating costs decreased to 675,384,458.77 CNY from 740,804,636.07 CNY, a reduction of about 8.8%[59] - The net profit for the current period is 62,519,729.43 CNY, down from 73,803,935.73 CNY in the previous period, indicating a decrease of about 15.5%[59] - The total comprehensive income for the current period is 62,410,867.55 CNY, compared to 71,657,483.74 CNY in the previous period, a decrease of about 12.4%[62] - The total comprehensive income amounted to ¥60,492,671.74, an increase from ¥23,972,321.17 in the previous period[69] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,958,227,827.34, reflecting a growth of 2.30% from ¥5,824,345,547.49 at the end of the previous year[10] - Total assets as of March 31, 2020, amounted to 5.96 billion yuan, an increase from 5.82 billion yuan at the end of 2019[37] - Total liabilities rose to CNY 1,223,463,237.20, up from CNY 1,159,281,844.07, indicating an increase of about 5.5%[53] - The company's total equity increased to CNY 2,776,799,679.71 from CNY 2,716,307,007.97, representing a growth of approximately 2.2%[53] - The total liabilities to equity ratio stands at approximately 44.1%, indicating a stable leverage position for the company[53] Cash Flow - The net cash flow from operating activities was ¥95,178,224.07, a decrease of 7.15% from ¥102,508,038.15 in the same period last year[10] - Cash inflow from operating activities totaled ¥742,048,619.04, down from ¥794,392,215.40 in the previous period, representing a decrease of approximately 6.6%[70] - Cash outflow from operating activities was ¥646,870,394.97, compared to ¥691,884,177.25 previously, indicating a decrease of about 6.5%[73] - Net cash flow from investing activities was -¥7,070,879.93, an improvement from -¥20,865,453.73 in the previous period[73] - Net cash flow from financing activities was ¥82,715,162.42, compared to -¥4,530,098.04 previously, showing a significant turnaround[76] - The cash and cash equivalents at the end of the period reached ¥878,050,916.64, up from ¥630,201,554.26, an increase of approximately 39.2%[76] - The company reported a net increase in cash and cash equivalents of ¥175,496,482.51, compared to ¥69,245,913.46 in the previous period, reflecting a growth of about 153.5%[76] Shareholder Information - The total number of shareholders at the end of the reporting period was 33,067, with the largest shareholder holding 21.55% of the shares[14] - The net assets attributable to shareholders increased to ¥3,008,770,589.18, up 2.29% from ¥2,941,524,857.14 at the end of the previous year[10] Receivables and Payables - Accounts receivable decreased by 52.07% compared to the beginning of the year, a reduction of 2.08 million yuan, mainly due to the collection of matured notes[22] - Financing receivables decreased by 35.24% compared to the beginning of the year, a reduction of 97.88 million yuan, primarily due to the payment of purchase amounts through note transfers[22] - Prepayments increased by 61.03% compared to the beginning of the year, an increase of 20.74 million yuan, mainly due to an increase in prepayments as per contracts[22] - Other receivables increased by 30% compared to the beginning of the year, an increase of 9.25 million yuan, mainly due to an increase in other temporary payments[22] - Other current assets decreased by 55.51% compared to the beginning of the year, a reduction of 30.59 million yuan, mainly due to a decrease in retained tax amounts and the maturity of structured deposits[22] Expenses - Financial expenses decreased by 48.53% compared to the same period last year, a reduction of 12.17 million yuan, mainly due to an increase in exchange gains[23] - Other income increased by 83.41% compared to the same period last year, an increase of 3.03 million yuan, mainly due to an increase in government subsidies received[23] - Research and development expenses increased to 28,260,023.13 CNY from 22,398,036.17 CNY, reflecting a rise of approximately 26.5%[59] - The company's sales expenses decreased to 207,988,438.87 CNY from 251,307,964.61 CNY, a reduction of approximately 17.2%[59] - The tax expenses for the current period are 4,826,080.73 CNY, down from 7,688,109.88 CNY, indicating a decrease of about 37.5%[59] Other Information - The company received government subsidies amounting to ¥6,656,275.45 during the reporting period[10] - The first quarter report for 2020 was not audited, which may affect the reliability of the financial data presented[93] - The company is implementing new revenue and lease standards starting in 2020, which may impact future financial reporting[93]